Carcinoembryonic Antigen CEA

Carcinoembryonic Antigen (CEA) is a protein that is present at elevated levels in various cancers, particularly in colorectal cancer. The MLCEA test is a diagnostic tool designed to detect and measure the concentration of CEA in the blood. This can be crucial for monitoring cancer progression, assessing treatment effectiveness, and detecting potential recurrences.

  • Price: £ 59
  • Code: MLCEA

Why Take the Carcinoembryonic Antigen CEA Test?

Detecting cancer early greatly increases the chances of successful treatment.

For individuals already diagnosed with cancer, the Carcinoembryonic Antigen CEA test helps monitor the effectiveness of treatment.

Carcinoembryonic Antigen CEA

Frequently Asked Questions

Carcinoembryonic Antigen (CEA) is a protein that is often elevated in the blood of individuals with certain types of cancer, especially colorectal cancer. The MLCEA test is a diagnostic tool to measure CEA levels.

CEA testing is important for monitoring cancer patients, as elevated CEA levels may indicate the presence of cancer, assess the effectiveness of treatment, and detect potential recurrences.

The MLCEA test is a blood test. A small sample of blood is taken, and the concentration of CEA is measured in the laboratory.

While CEA is often associated with colorectal cancer, elevated levels can also be found in other cancers. The MLCEA test may be recommended for various cancer types where CEA monitoring is relevant.

Yes, CEA levels can be elevated in non-cancerous conditions such as inflammation, liver disease, and certain infections. It is important to consult with a healthcare professional for proper interpretation of CEA test results.

The MLCEA test is typically used for monitoring cancer patients rather than routine screening for the general population. Consult with your healthcare provider to determine if CEA testing is appropriate for your situation.